Cargando…
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165386/ https://www.ncbi.nlm.nih.gov/pubmed/34079770 http://dx.doi.org/10.3389/fcimb.2021.684515 |
_version_ | 1783701310729617408 |
---|---|
author | Boyd, Natalie K. Teng, Chengwen Frei, Christopher R. |
author_facet | Boyd, Natalie K. Teng, Chengwen Frei, Christopher R. |
author_sort | Boyd, Natalie K. |
collection | PubMed |
description | Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as “antibiotic adjuvants” to enhance the activity of certain antibiotics. |
format | Online Article Text |
id | pubmed-8165386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81653862021-06-01 Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing Boyd, Natalie K. Teng, Chengwen Frei, Christopher R. Front Cell Infect Microbiol Cellular and Infection Microbiology Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as “antibiotic adjuvants” to enhance the activity of certain antibiotics. Frontiers Media S.A. 2021-05-17 /pmc/articles/PMC8165386/ /pubmed/34079770 http://dx.doi.org/10.3389/fcimb.2021.684515 Text en Copyright © 2021 Boyd, Teng and Frei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Boyd, Natalie K. Teng, Chengwen Frei, Christopher R. Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title | Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title_full | Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title_fullStr | Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title_full_unstemmed | Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title_short | Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
title_sort | brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165386/ https://www.ncbi.nlm.nih.gov/pubmed/34079770 http://dx.doi.org/10.3389/fcimb.2021.684515 |
work_keys_str_mv | AT boydnataliek briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing AT tengchengwen briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing AT freichristopherr briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing |